Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Receivables: 2017-2025

Historic Change in Receivables for Assembly Biosciences (ASMB) over the last 7 years, with Sep 2025 value amounting to $912,000.

  • Assembly Biosciences' Change in Receivables was N/A to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $570,000, marking a year-over-year change of. This contributed to the annual value of -$43,000 for FY2024, which is 95.23% up from last year.
  • Per Assembly Biosciences' latest filing, its Change in Receivables stood at $912,000 for Q3 2025, which was up 2,220.93% from -$43,000 recorded in Q2 2024.
  • Assembly Biosciences' Change in Receivables' 5-year high stood at $912,000 during Q3 2025, with a 5-year trough of -$1.0 million in Q1 2021.
  • Over the past 3 years, Assembly Biosciences' median Change in Receivables value was -$135,000 (recorded in 2023), while the average stood at -$5,333.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 118.31% in 2022, then slumped by 37,400.00% in 2023.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Change in Receivables stood at -$433,000 in 2021, then soared by 30.25% to -$302,000 in 2022, then soared by 114.24% to $43,000 in 2023, then soared by 88.53% to -$43,000 in 2024, then reached $912,000 in 2025.
  • Its Change in Receivables stands at $912,000 for Q3 2025, versus -$43,000 for Q2 2024 and $43,000 for Q4 2023.